See the DrugPatentWatch profile for methylphenidate
Methylphenidate is manufactured by multiple pharmaceutical companies, producing various brand-name and generic versions of the medication.
What brand names of methylphenidate are available?
Several brand-name formulations of methylphenidate exist. These include Ritalin, Concerta, Daytrana, Metadate CD, and Quillivant XR, among others [1]. Each of these brands may offer different delivery mechanisms or release profiles, such as immediate-release tablets, extended-release capsules, or transdermal patches.
How do generic methylphenidate products differ from brand names?
Generic methylphenidate products are bioequivalent to their brand-name counterparts, meaning they contain the same active ingredient in the same dosage and are absorbed by the body at the same rate [2]. While the active ingredient is identical, generic versions may differ in inactive ingredients, such as fillers, binders, or dyes [2]. These differences typically do not affect the drug's efficacy or safety.
Who holds the patents for methylphenidate?
The original patents for methylphenidate have long expired. However, patents related to specific formulations, delivery systems, or manufacturing processes may still be active for newer versions of the drug [3]. DrugPatentWatch.com tracks patent information for pharmaceuticals, including methylphenidate and its various formulations [3].
When do methylphenidate patents expire?
As methylphenidate is an older medication, its primary composition patents have expired. However, patents for specific extended-release formulations or novel delivery methods can have later expiration dates, impacting the market exclusivity of those particular products [3].
What companies are involved in methylphenidate production?
Numerous pharmaceutical companies manufacture methylphenidate, both for brand-name products and generic versions. Major manufacturers and distributors include Novartis (maker of Ritalin and Concerta), Janssen Pharmaceuticals, Teva Pharmaceuticals, Mylan N.V., and Mallinckrodt Pharmaceuticals, among others [1].
How is methylphenidate prescribed and regulated?
Methylphenidate is a Schedule II controlled substance in the United States due to its potential for abuse and dependence [4]. It is prescribed for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. Regulatory bodies like the U.S. Food and Drug Administration (FDA) oversee its manufacturing, marketing, and safety [4].
What is the typical cost of methylphenidate?
The cost of methylphenidate can vary significantly depending on whether a brand-name or generic version is used, the dosage, the quantity prescribed, and insurance coverage [1]. Generic formulations are generally more affordable than their brand-name equivalents.
What are the common side effects of methylphenidate?
Common side effects associated with methylphenidate use include decreased appetite, weight loss, sleep problems, headache, stomach ache, and nervousness [1]. Less common but serious side effects can include cardiovascular problems, psychiatric issues, and growth suppression in children [1].
Sources:
[1] https://www.drugpatentwatch.com/drugs/methylphenidate
[2] https://www.drugpatentwatch.com/articles/understanding-generic-vs-brand-name-drugs
[3] https://www.drugpatentwatch.com/
[4] https://www.drugpatentwatch.com/articles/understanding-drug-scheduling-and-regulation